Logo image of DCBO

DOCEBO INC (DCBO) Stock Fundamental Analysis

USA - NASDAQ:DCBO - CA25609L1058 - Common Stock

26.285 USD
+0.52 (+2%)
Last: 10/17/2025, 8:05:41 PM
26.285 USD
0 (0%)
After Hours: 10/17/2025, 8:05:41 PM
Fundamental Rating

6

Taking everything into account, DCBO scores 6 out of 10 in our fundamental rating. DCBO was compared to 283 industry peers in the Software industry. Both the profitability and the financial health of DCBO get a neutral evaluation. Nothing too spectacular is happening here. DCBO is growing strongly while it is still valued neutral. This is a good combination! These ratings could make DCBO a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

DCBO had positive earnings in the past year.
DCBO had a positive operating cash flow in the past year.
In multiple years DCBO reported negative net income over the last 5 years.
Of the past 5 years DCBO 4 years had a positive operating cash flow.
DCBO Yearly Net Income VS EBIT VS OCF VS FCFDCBO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

DCBO has a Return On Assets of 12.51%. This is amongst the best in the industry. DCBO outperforms 89.44% of its industry peers.
DCBO has a Return On Equity of 61.75%. This is amongst the best in the industry. DCBO outperforms 96.83% of its industry peers.
Looking at the Return On Invested Capital, with a value of 32.53%, DCBO belongs to the top of the industry, outperforming 97.18% of the companies in the same industry.
Industry RankSector Rank
ROA 12.51%
ROE 61.75%
ROIC 32.53%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
DCBO Yearly ROA, ROE, ROICDCBO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

1.3 Margins

DCBO's Profit Margin of 9.29% is fine compared to the rest of the industry. DCBO outperforms 72.54% of its industry peers.
The Operating Margin of DCBO (9.67%) is better than 74.30% of its industry peers.
With an excellent Gross Margin value of 81.00%, DCBO belongs to the best of the industry, outperforming 84.15% of the companies in the same industry.
DCBO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.67%
PM (TTM) 9.29%
GM 81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
DCBO Yearly Profit, Operating, Gross MarginsDCBO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), DCBO is creating value.
The number of shares outstanding for DCBO remains at a similar level compared to 1 year ago.
Compared to 5 years ago, DCBO has more shares outstanding
Compared to 1 year ago, DCBO has an improved debt to assets ratio.
DCBO Yearly Shares OutstandingDCBO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DCBO Yearly Total Debt VS Total AssetsDCBO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

DCBO has an Altman-Z score of 3.33. This indicates that DCBO is financially healthy and has little risk of bankruptcy at the moment.
With a Altman-Z score value of 3.33, DCBO perfoms like the industry average, outperforming 59.15% of the companies in the same industry.
DCBO has a debt to FCF ratio of 0.05. This is a very positive value and a sign of high solvency as it would only need 0.05 years to pay back of all of its debts.
DCBO has a better Debt to FCF ratio (0.05) than 82.75% of its industry peers.
DCBO has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of DCBO (0.01) is better than 64.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Altman-Z 3.33
ROIC/WACC3.06
WACC10.62%
DCBO Yearly LT Debt VS Equity VS FCFDCBO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

DCBO has a Current Ratio of 1.04. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of DCBO (1.04) is worse than 70.07% of its industry peers.
DCBO has a Quick Ratio of 1.04. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.04, DCBO is not doing good in the industry: 69.37% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 1.04
DCBO Yearly Current Assets VS Current LiabilitesDCBO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 103.70% over the past year.
Looking at the last year, DCBO shows a quite strong growth in Revenue. The Revenue has grown by 15.11% in the last year.
The Revenue has been growing by 39.25% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)103.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.33%
Revenue 1Y (TTM)15.11%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%14.47%

3.2 Future

DCBO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.76% yearly.
The Revenue is expected to grow by 24.94% on average over the next years. This is a very strong growth
EPS Next Y37.82%
EPS Next 2Y33.47%
EPS Next 3Y34.47%
EPS Next 5Y27.76%
Revenue Next Year11.22%
Revenue Next 2Y9.78%
Revenue Next 3Y9.84%
Revenue Next 5Y24.94%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DCBO Yearly Revenue VS EstimatesDCBO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
DCBO Yearly EPS VS EstimatesDCBO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 23.90, DCBO is valued on the expensive side.
DCBO's Price/Earnings ratio is a bit cheaper when compared to the industry. DCBO is cheaper than 71.83% of the companies in the same industry.
DCBO's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.40.
The Price/Forward Earnings ratio is 17.16, which indicates a rather expensive current valuation of DCBO.
Based on the Price/Forward Earnings ratio, DCBO is valued a bit cheaper than the industry average as 79.23% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of DCBO to the average of the S&P500 Index (22.94), we can say DCBO is valued slightly cheaper.
Industry RankSector Rank
PE 23.9
Fwd PE 17.16
DCBO Price Earnings VS Forward Price EarningsDCBO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DCBO is valued a bit cheaper than the industry average as 76.76% of the companies are valued more expensively.
73.59% of the companies in the same industry are more expensive than DCBO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 28.07
EV/EBITDA 26.96
DCBO Per share dataDCBO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DCBO has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as DCBO's earnings are expected to grow with 34.47% in the coming years.
PEG (NY)0.63
PEG (5Y)N/A
EPS Next 2Y33.47%
EPS Next 3Y34.47%

0

5. Dividend

5.1 Amount

DCBO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DOCEBO INC

NASDAQ:DCBO (10/17/2025, 8:05:41 PM)

After market: 26.285 0 (0%)

26.285

+0.52 (+2%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-07 2025-11-07
Inst Owners31.4%
Inst Owner Change0%
Ins Owners1.51%
Ins Owner ChangeN/A
Market Cap755.17M
Analysts78.67
Price Target29.69 (12.95%)
Short Float %2.2%
Short Ratio3.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.06%
Min EPS beat(2)26.05%
Max EPS beat(2)28.07%
EPS beat(4)3
Avg EPS beat(4)41.65%
Min EPS beat(4)-25.3%
Max EPS beat(4)137.79%
EPS beat(8)7
Avg EPS beat(8)31.82%
EPS beat(12)10
Avg EPS beat(12)131.11%
EPS beat(16)13
Avg EPS beat(16)110.84%
Revenue beat(2)1
Avg Revenue beat(2)-0.14%
Min Revenue beat(2)-1.61%
Max Revenue beat(2)1.34%
Revenue beat(4)2
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.44%
Revenue beat(12)2
Avg Revenue beat(12)-0.71%
Revenue beat(16)3
Avg Revenue beat(16)-0.87%
PT rev (1m)-0.94%
PT rev (3m)1.6%
EPS NQ rev (1m)1.02%
EPS NQ rev (3m)14.58%
EPS NY rev (1m)1.75%
EPS NY rev (3m)-1.21%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)1.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.48%
Valuation
Industry RankSector Rank
PE 23.9
Fwd PE 17.16
P/S 3.28
P/FCF 28.07
P/OCF 26.73
P/B 21.77
P/tB 40.16
EV/EBITDA 26.96
EPS(TTM)1.1
EY4.18%
EPS(NY)1.53
Fwd EY5.83%
FCF(TTM)0.94
FCFY3.56%
OCF(TTM)0.98
OCFY3.74%
SpS8.02
BVpS1.21
TBVpS0.65
PEG (NY)0.63
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.51%
ROE 61.75%
ROCE 55.51%
ROIC 32.53%
ROICexc N/A
ROICexgc N/A
OM 9.67%
PM (TTM) 9.29%
GM 81%
FCFM 11.67%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
F-Score8
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Debt/EBITDA 0.01
Cap/Depr 39.68%
Cap/Sales 0.58%
Interest Coverage 250
Cash Conversion 110.06%
Profit Quality 125.62%
Current Ratio 1.04
Quick Ratio 1.04
Altman-Z 3.33
F-Score8
WACC10.62%
ROIC/WACC3.06
Cap/Depr(3y)34.45%
Cap/Depr(5y)55.59%
Cap/Sales(3y)0.56%
Cap/Sales(5y)1.02%
Profit Quality(3y)220.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.33%
EPS Next Y37.82%
EPS Next 2Y33.47%
EPS Next 3Y34.47%
EPS Next 5Y27.76%
Revenue 1Y (TTM)15.11%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%14.47%
Revenue Next Year11.22%
Revenue Next 2Y9.78%
Revenue Next 3Y9.84%
Revenue Next 5Y24.94%
EBIT growth 1Y84.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year125.27%
EBIT Next 3Y50.67%
EBIT Next 5Y32.58%
FCF growth 1Y380.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y338.61%
OCF growth 3YN/A
OCF growth 5YN/A